Waldman Meryl, Marshall Vickie, Whitby Denise, Kopp Jeffrey B
Kidney Disease Section, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-1268, USA.
Semin Nephrol. 2008 Nov;28(6):595-607. doi: 10.1016/j.semnephrol.2008.08.010.
Human immunodeficiency virus (HIV)-infected patients may acquire new viral co-infections; they also may experience the reactivation or worsening of existing viral infections, including active, smoldering, or latent infections. HIV-infected patients may be predisposed to these viral infections owing to immunodeficiency or risk factors common to HIV and other viruses. A number of these affect the kidney, either by direct infection or by deposition of immune complexes. In this review we discuss the renal manifestations and treatment of hepatitis C virus, BK virus, adenovirus, cytomegalovirus, and parvovirus B19 in patients with HIV disease. We also discuss an approach to the identification of new viral renal pathogens, using a viral gene chip to identify viral DNA or RNA.
感染人类免疫缺陷病毒(HIV)的患者可能会发生新的病毒合并感染;他们也可能经历现有病毒感染的重新激活或恶化,包括活动性、隐匿性或潜伏性感染。由于免疫缺陷或HIV与其他病毒共有的危险因素,HIV感染患者可能易患这些病毒感染。其中一些病毒感染通过直接感染或免疫复合物沉积影响肾脏。在本综述中,我们讨论了HIV感染患者中丙型肝炎病毒、BK病毒、腺病毒、巨细胞病毒和细小病毒B19的肾脏表现及治疗。我们还讨论了一种使用病毒基因芯片鉴定病毒DNA或RNA来识别新的病毒性肾脏病原体的方法。